Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal | Zendy

Anna Chiara Frigo | Zendy; Angela Dardano | Zendy; Elisa Danese | Zendy; Maria Vittoria Davì | Zendy; Paolo Moghetti | Zendy; Chiara Colato | Zendy; Giuseppe Francia | Zendy; Franca Bernardi | Zendy; Claudio Traino | Zendy; Fabio Monzani | Zendy; M Ferdeghini | Zendy

Open Access

Chromosome Translocation Frequency after Radioiodine Thyroid Remnant Ablation: A Comparison between Recombinant Human Thyrotropin Stimulation and Prolonged Levothyroxine Withdrawal

Author(s) -

Anna Chiara Frigo,

Angela Dardano,

Elisa Danese,

Maria Vittoria Davì,

Paolo Moghetti,

Chiara Colato,

Giuseppe Francia,

Franca Bernardi,

Claudio Traino,

Fabio Monzani,

M Ferdeghini

Publication year - 2009

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2008-2830

Subject(s) - levothyroxine , medicine , endocrinology , recombinant dna , thyroid , ablation , thyroid carcinoma , stimulation , chromosomal translocation , hormone , biology , gene , biochemistry

Thyroid remnant ablation of differentiated thyroid carcinoma (DTC) patients is traditionally performed after levothyroxine withdrawal. Recombinant human TSH (rhTSH) administration increases serum TSH levels without inducing hypothyroidism.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research